Luc Sterkman
Directeur Général chez Caelus Pharmaceuticals BV
Profil
Luc Sterkman is currently the Chief Executive Officer at Caelus Pharmaceuticals BV.
Previously, he worked as a Principal at Kendle International LLC, a Member-Management Board at Dr. Reddy's Research & Development BV, and as the Chief Operating Officer at Newtricious BV.
Postes actifs de Luc Sterkman
| Sociétés | Poste | Début |
|---|---|---|
Caelus Pharmaceuticals BV
 Caelus Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Caelus Pharmaceuticals BV operates as a biotechnology company that develops microbiome therapeutics for the reduction of insulin resistance and prevention of type 2 diabetes in people with metabolic syndrome. The firm is dedicated to the commercialisation of functional food and pharmabiotic products for the prevention and early treatment of cardio metabolic diseases-based on the correlation between the intestinal microbiome and health. The company was founded by Willem de Vos and Max Nieuwdorp and is headquartered in Amsterdam, the Netherlands. | Directeur Général | - |
Anciens postes connus de Luc Sterkman
| Sociétés | Poste | Fin |
|---|---|---|
Kendle International LLC
 Kendle International LLC Miscellaneous Commercial ServicesCommercial Services Kendle International LLC provides research and development services to biopharmaceutical companies by offering value-added clinical research services and proprietary information technology. The company was founded in 1981 and is headquartered in Cincinnati, OH. | Corporate Officer/Principal | - |
Dr. Reddy's Research & Development BV
 Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands. | Corporate Officer/Principal | - |
Newtricious BV
 Newtricious BV Food: Major DiversifiedConsumer Non-Durables Newtricious BV develops active food ingredients and products for health maintenance. It focuses on health areas, such as, obesity, metabolic syndrome, eye health, cardiovascular health, and diabetes. The company was founded by Jos Nelissen and Marieëtte Nelissen in 2006 and is headquartered in Oirlo, the Netherlands. | Directeur des opérations | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Newtricious BV
Newtricious BV Food: Major DiversifiedConsumer Non-Durables Newtricious BV develops active food ingredients and products for health maintenance. It focuses on health areas, such as, obesity, metabolic syndrome, eye health, cardiovascular health, and diabetes. The company was founded by Jos Nelissen and Marieëtte Nelissen in 2006 and is headquartered in Oirlo, the Netherlands. | Consumer Non-Durables |
Kendle International LLC
Kendle International LLC Miscellaneous Commercial ServicesCommercial Services Kendle International LLC provides research and development services to biopharmaceutical companies by offering value-added clinical research services and proprietary information technology. The company was founded in 1981 and is headquartered in Cincinnati, OH. | Commercial Services |
Dr. Reddy's Research & Development BV
Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands. | Health Technology |
Caelus Pharmaceuticals BV
Caelus Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Caelus Pharmaceuticals BV operates as a biotechnology company that develops microbiome therapeutics for the reduction of insulin resistance and prevention of type 2 diabetes in people with metabolic syndrome. The firm is dedicated to the commercialisation of functional food and pharmabiotic products for the prevention and early treatment of cardio metabolic diseases-based on the correlation between the intestinal microbiome and health. The company was founded by Willem de Vos and Max Nieuwdorp and is headquartered in Amsterdam, the Netherlands. | Health Technology |
